Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
NCT00302536
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
There was less patients recruited.
Conditions
Focal Glomerulosclerosis
Interventions
DRUG:
Tacrolimus
Sponsor
Nanjing University School of Medicine